Therapeutic Targeting of Retinal Immune Microenvironment With CSF-1 Receptor Antibody Promotes Visual Function Recovery After Ischemic Optic Neuropathy is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0.520. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Natural Science Foundation of China
Grant: 81790641
National Institutes of Health
Grant: EY025913, EY025259, P30EY03790
NEI NIH HHS
Grant: R01 EY025259
NEI NIH HHS
Grant: R44 EY025913
NEI NIH HHS
Grant: R41 EY025913
NEI NIH HHS
Grant: P30 EY003790
National Institutes of Health
Grant: 5R44EY025913-03
Development of a Next Generation Visual Performance Assessment System for Rodents
National Institutes of Health
Grant: 5P30EY003790-10
CORE GRANT FOR VISION RESEARCH
National Institutes of Health
Grant: 5R01EY025259-04
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration
FWCI
1.27
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals